Author:
Koch Muffy,Pence Matthew G.,DeMond Jaylee,Rudgers Gary
Abstract
Small procedural changes in how regulatory agencies implement biotech policies can make significant differences in improving regulatory efficiency. This paper discusses how science based, crop specific guidance documents can improve dossier content and the review and approval of biotech varieties. In addition, we describe how the adoption of established risk assessment methodology and applying policy-linked decision making at the agency level can boost both efficiency and developer, public and government confidence in agency decision making and in biotech crops.
Reference11 articles.
1. Time and cost to develop a new GM trait. Study report2022
2. Data transportability for studies performed to support an environmental risk assessment for genetically modified (GM) crops;Bachman;J. Reg. Sci.,2021
3. Global status of commercialized biotech/GM crops in 2019: biotech crops drive socio-economic development and sustainable environment in the New Frontier,2019
4. MARD circular 2/2014/TT-BNNPTNT2014
5. Transportability of confined field trial data from cultivation to import countries for environmental risk assessment of genetically modified crops;Nakai;Transgenic Res.,2015